Contact this trialFirst, we need to learn more about you.
Procedure
iLAST for Depression
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing a new, safer way to give electroconvulsive therapy (ECT) called iLAST. ECT is used to treat people with severe depression and can cause memory loss as a side effect. The trial will last up to 20 weeks, during which participants will have various tests to see if iLAST is safe and feasible.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service